DCLK1 and neoplasm: We previously revealed that DCLK1 overexpression was correlated with PCa tumor aggressiveness and might effectively predict poor biochemical recurrence-free survival outcomes in patients after radical prostatectomy 10, but the related underlying molecular mechanism remains obscure.